Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Dog Vaccine Market

Dog Vaccine Market Share

Report ID: GMI9817
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Dog Vaccine Market Share

The dog vaccines industry is characterized by prominent players offering wide array of vaccines targeting various canine diseases. These companies boast established reputations and extensive distribution networks. The emerging players are gaining traction, focusing on innovative vaccine formulations and expanding their market presence. Competition is fierce, with companies competing on product efficacy, safety, pricing, and market reach. The dynamic nature of the market ensures ongoing evolution as new entrants enter and existing players innovate to maintain their competitive edge.

Dog Vaccine Market Companies

Some of the prominent players operating in the dog vaccine industry include:

Bioveta, a.s.
Boehringer Ingelheim International GmbH
Brilliant Bio Pharma
Creative Biolabs
Elanco Animal Health Incorporated
Merck & Co., Inc.
NEOTECH, LLC
Virbac
Zendal Group
Zoetis Inc.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of dog vaccine reached USD 1.8 billion in 2023 and is set to witness 5.8% CAGR from 2024 to 2032, owing to the increasing awareness of pet health coupled with rising incidences of canine diseases.

The live attenuated vaccine type segment in the dog vaccine industry accounted for USD 800.4 million in 2023, as it provides effective and durable protection against various canine diseases.

The canine parvovirus disease type segment recorded 25.3% share in 2023, owing to its high contagiousness and severe impact on canine health.

U.S. market size was USD 683.4 million in 2023, led by the presence of large population of pet dogs and well-established veterinary health infrastructure and clinics.